Haier Biomedical News

Haier Biomedical Distributor Conference Concluded

On May 21, Haier Biomedical Overseas Distributors Conference was successfully concluded in Qingdao., where distributors from dozens of countries and regions around the world gathered to join Haier Biomedical in a grand event. The conference summarized the past achievements of Haier Biomedical and shared the future development strategies and plans, aiming to achieve mutual benefits and win-win with partners.

Haier Biomedical Supports Pasteur Research


Together Creating Better Future Through the Intelligent Protection of Life Science

Haier Biomedical’s Annual Distributor Conference was successfully held in Qingdao in May 2023 with the theme of together creating a better future through the intelligent protection of life science, where distributors, partners and key stakeholders from dozens of countries and regions around the world gathered to discuss the future with Haier Biomedical. The conference summarized Haier Biomedical's past achievements and shared its future strategies and plans, to implement its brand development concept in life science and medical innovation with quality product solutions and services.

HB Supports MG’s Vaccine Cold Chain

the U.S. government has purchased 1 million of Haier Biomedical equipment through the US International Development Agency to fund the infrastructure of the national health system of Madagascar

Haier Biomedical Product Assistance Gabon

the Japanese government purchased several sets of equipment from Haier Biomedical through UNICEF for Gabon’s health system, including Cold Room, Solar Vaccine Refrigerators, Transport Cooler and other equipment, aiming to improve Gabon’s vaccine cold chain system

The Future Development of Chinese Vaccines

With the global outbreak of the COVID-19, the vaccine industry was pushed to forefront and knowledge reached the public about vaccination, more than anytime previously in history.

Haier Biomedical 2023 AACR exhibition was a success

Haier Biomedical showcased biobank and laboratory solutions and products to customers and partners during AACR

Haier Biomedical’s 2022 Corporate Social Responsibility Report Released

Haier Biomedical’s operating income in 2022 was $41.43million


Science and technology lead the new trend of ultra-low temperature preservation

Technology created the ultra-low temperature environment, quality protects the entire environment" - leading the technological innovation of the industry and opening a new era of medical refrigeration

1 2 3 4 5